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Abstract 
Percutaneous transluminal coronary angioplasty (PTCA) and stent has become 
the most commonly performed cardiac procedure in Australia over the last decade. This 
study investigated the level of anxiety experienced by patients who were undergoing 
elective PTCA and stent procedures. Anxiety was assessed at three specific times, in-
hospital pre-procedure, within 18 hours after the procedure, and one-week post 
discharge, using two methods to assess anxiety, the State Anxiety Inventory and the 
Faces Anxiety Scale. 
The sample (n = 1 00) was predominantly elderly (mean 65.63 years), male 
(80%) and married (83%). Most participants (70%) had previously experienced a 
cardiac event, of which the most common was PTCA and stent (41 %). Almost half of 
the participants had experienced unstable angina ( 4 7%) and the most frequent 
concurrent condition was hypertension (67o/o). 
The results confirm that most people were not clinically anxious as anxiety SAI 
scores ranged from 37.72 (mean) pre-procedure and decreased over time to 31.8 (mean) 
post procedure and again post discharge 28.79 (mean). However, there is a significant 
group of participants that experienced more than normal levels of anxiety pre 
procedure (49%), post procedure (32%) and post discharge (19%) .. The independent 
predictors of anxiety were also identified through multiple regression analysis . . 
Participants at risk of pre-procedure anxiety were those taking medications for the 
management of the symptoms of anxiety and depression. The predictors of post 
procedure anxiety included anxiety pre-procedure, having chest pain post procedure, or 
Vlll 
undergoing a PTCA and stent procedure for the first-time. Again, post discharge 
patients were more likely to be anxious if they were anxious pre-procedure and they 
reported their major concern to be related to the future progression of their coronary 
artery disease. The Faces Anxiety Scale proved to have low sensitivity and moderate 
specificity in this sample. 
The conclusion is that anxiety is relatively common and needs to be identified 
and treated, particularly pre-procedure to decrease subsequent anxiety. An instrument 
to detect anxiety quickly and accurately needs to be developed for clinical use. 
